期刊文献+

塞来昔布对心脏钠离子通道Na_v1.5电生理特性的影响 被引量:1

Effect of Celecoxib on Electrophysiological Property of Cardiac Sodium Channel Na_v1.5
下载PDF
导出
摘要 针对塞来昔布对与心脏毒性密切相关的钠离子通道Na_v1. 5电生理特性的影响进行了研究.采用全细胞膜片钳技术,检测塞来昔布对Na_v1. 5的电生理特性的影响,包括电流峰值、电压依赖性激活、电压依赖性失活以及恢复动力学.研究结果表明,塞来昔布对Na_v1. 5的峰电流具有抑制作用,且呈浓度依赖性,其抑制作用的IC50值为1. 54×10-8mol/L;塞来昔布促进了Na_v1. 5的激活及失活过程,使其难以恢复到静息状态.塞来昔布对Na_v1. 5峰电流的明显抑制作用,表明其潜在的心脏风险可能与Na_v1. 5密切相关. The effect of celecoxib on electrophysiological property of Na v1.5 was studied,which was associated with cardiac toxicity.The effects of celecoxib on the electrophysiological properties of Nav1.5,including peak current,voltage-dependent activation,voltage-dependent inactivation and recovery kinetics,were investigated by whole cell patch clamp technique.The results showed that celecoxib inhibited the peak currents of Nav1.5 in a concentration-dependent manner with a calculated IC50 value of 1.54×10^-8 mol/L.Moreover,celecoxib promoted the activation and inactivation phase of Nav1.5,making it somewhat difficult to recover from the inactivation to the resting state.The prominent inhibition of celecoxib on Nav1.5 indicated that there might be a close relationship between potential cardiovascular risks and Nav1.5.
作者 孙健芳 徐艺珈 王占友 SUN Jian-fang;XU Yi-jia;WANG Zhan-you(School of Life and Health Sciences,Northeastern University,Shenyang 110169,China;School of Life Sciences and Biopharmaceutical Science,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《东北大学学报(自然科学版)》 EI CAS CSCD 北大核心 2019年第3期452-456,共5页 Journal of Northeastern University(Natural Science)
基金 辽宁省教育厅创新团队项目(LT2015010)
关键词 塞来昔布 心血管风险 全细胞膜片钳 NAV1.5 电生理特性 celecoxib cardiovascular risk whole cell patch clamp Na v1.5 electrophysiological property
  • 相关文献

参考文献2

二级参考文献16

  • 1左朝晖,谌忠友,莫胜川,周晓,肖斌生,吴胜其.肝细胞癌及癌旁组织中环氧合酶-2的表达及临床意义[J].肿瘤研究与临床,2005,17(5):309-312. 被引量:5
  • 2Masferrer J L,Leahy K M,Koki A T,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res,2000,60(5):1306-1311.
  • 3Fidler I,Ellis L M.The implications of angiogenesis for the biology and therapy of cancer metastasis[J].Cell,1994,79(2):185-188.
  • 4Moon W S,Rhyu K H,Kang M J,et al.Overexpression of VEGF and angiopoietin 2:a key to high vascularity of hepatocellular carcinoma[J].Mod Pathol,2003,16(6):552-557.
  • 5Yoshiji H,Kuriyama S,Yoshii J,et al.Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma[J].Hepatology,2002,35 (4):834-842.
  • 6Maisonpierre P C,Suri C,Jones P F,et al.Angiopoientin-2,a natural antagonist tor Tie 2 that disrupts in vivo angiogenesis[J].Science,1997,277 (5322):55-60.
  • 7Liu X H,Kirschenbaum A,Yao S,et al.Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo[J].J Urol,2000,164(3):820-835.
  • 8Thun M J,Namboodiri M M,Heath C M.Aspirin use and reduced risk of fatal colon cancer[J].N Engl J Med,1991,325(23):1593-1596.
  • 9Eberhart C E,Coffey R J,Radhika A,et al.Upregulation of cyclooxygcnase 2 gene expression in human colorectal adenomas and adenocarcinomas[J].Gastroenterology,1994,107(4):1183-1188.
  • 10Tsujii M,kamano S,Tsujiz S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells[J].Cell,1998,93(5):705-716.

共引文献28

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部